Kfar-Sava, Israel Clinical Trials

A listing of Kfar-Sava, Israel clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 123 clinical trials
Registry for Patients With X-linked Hypophosphatemia

This is an international, multicentre, prospective, non-interventional, observational registry of patients with X-linked hypophosphatemia (XLH). The main objective of this XLH registry is to collect data to characterise the treatment, progression and long-term outcomes of XLH in both adult and paediatric settings.

Schneider Medical Center
 (6.6 away) Contact site
  • 15 Mar, 2021
  • +105 other locations
Risk Stratification in Severe Treatment-naive Tricuspid Regurgitation

This registry is aimed to characterize patients with severe tricuspid regurgitation for the purpose of patient selection for interventional treatment and identify factors related to adverse outcomes.

Rabin Medical Centre
 (9.7 away) Contact site
  • 25 Jan, 2021
  • +4 other locations
Study to Evaluate the Real-World Long-Term Effectiveness of Lanadelumab in Participants With Hereditary Angioedema (HAE)

The purpose of this non-interventional, prospective study is to evaluate the real world long-term effectiveness of lanadelumab in participants with type 1 or type 2 HAE.

Sheba Medical Center - PPDS
 (9.0 away) Contact site
  • 25 Jan, 2021
  • +15 other locations
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

This study is referred to as the "umbrella master protocol" for pembrolizumab (MK-3475) in the treatment of non-small cell lung cancer (NSCLC). This pembrolizumab NSCLC umbrella master protocol uses a platform design and consists of this master screening study and three substudies. Each substudy will enroll a different population of …

cancer chemotherapy
targeted therapy
progressive disease
stage iv non-small cell lung cancer
Rabin Medical Center ( Site 0074)
 (6.6 away) Contact site
  • 20 Jun, 2021
  • +24 other locations
Physical Restraint of Critically Ill Patients

Background: Physical restraint of patients in the intensive care unit (ICU) is a common practice, with estimated prevalence of 50% of all ICU patients, with and without invasive ventilation support(1). The prevalence of physical restraint varies between ICU's according to patient population (surgical, cardiac, trauma, burns and general intensive care …

  • 15 Mar, 2021
  • 1 location
Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility Treatment

The purpose of this retrospective observational study is to describe the treatment patterns with MENOPUR and to understand the clinical impact for patients that underwent infertility treatment under real-world setting. The primary objective is to describe the treatment patterns for the general population and for selected patient profiles.

Assuta Medical Center Ltd
 (9.7 away) Contact site
  • 27 Apr, 2021
  • 1 location
Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.

This is a multi-centre, multi-country retrospective cohort study. At least 450COVID-19 cases from up to 20 participating study sites who meet all eligibility criteria will be included in the analysis. Deidentified data will be extracted from electronic medical record (EMR) databases, clinical registries, case series or additional sources from participating …

Tel Aviv Sourasky Medical Center
 (9.7 away) Contact site
  • 28 Apr, 2021
  • +10 other locations
Impact of Exposure to Environmental Pollutants on Birth Outcomes in an Israeli Cohort

Objectives and hypothesis The scale and diversity of chemicals in worldwide use today is vast. Many of these chemicals are released into the environment where they are found in air, water, soil, house dust, and in the food supply, resulting in exposure to humans. Characterizing the extent of exposure and …

Lis Medical Center
 (9.7 away) Contact site
  • 21 Jan, 2021
  • +1 other locations
Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

This study is being performed as a post-approval safety study (PASS), per the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), to gather data on Translarna (ataluren) safety, effectiveness, and prescription patterns in routine clinical practice.

muscular dystrophy
nonsense mutation
Schneider Medical Center Tel Aviv University
 (6.6 away) Contact site
  • 06 Jun, 2021
  • +100 other locations
Firazyr Patient Registry (Icatibant Outcome Survey - IOS)

The Icatibant Outcome Survey (IOS) is a prospective, observational disease registry designed to document the routine clinical outcomes over time in participants with angioedema treated with Firazyr (icatibant) and/or Cinryze (C1 inhibitor [human]) in countries where it is currently approved. The data collected will be used to evaluate the safety …

c1 inhibitor (human)
Rabin Medical Center - PPDS
 (6.6 away) Contact site
  • 25 Jan, 2021
  • +106 other locations